allergic reaction to glp-1 Dermal Hypersensitivity Semaglutide: Two Case Reports Hypersensitivity to glucagon‐like peptide‐1 receptor

Supports Muscle Mass: Provides essential amino acids that help preserve lean muscle mass during weight loss efforts

Quick Answer: GLP-1 receptor agonists are not FDA-approved for lipedema and lack high-quality clinical trial evidence, though preliminary case reports suggest potential symptomatic benefits

Key Benefits: Enhanced Bioavailability: Sublingual delivery avoids digestive degradation for faster, more effective absorption

Product claims describe established nutrient roles and the intended structure/function uses of individual ingredients

Limitations The patient submitted her diet through a form which increases the risk of reporting bias